Has Teresa Duncan received payments from drug or device companies?

Yes. Drug and device makers reported $492 in general payments to Teresa Duncan across 20 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Teresa Duncan did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Teresa Duncan come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Teresa Duncan

Psychiatric/Mental Health · Cambridge, MNNPI 1417382839

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Neuronetics, Inc. at 30.6% of the total. Reporting peaked in 2023 at $220 and has fallen 61.1% since, to $86 in 2025. Among psychiatric/mental health clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$492in general payments, 2019–2025

Across 20 payments — averaging $24.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Neuronetics, Inc.$150
Supernus Pharmaceuticals, Inc.$85
Indivior Inc.$46
Vanda Pharmaceuticals Inc.$36
Teva Pharmaceuticals USA, Inc.$34
Neurocrine Biosciences, Inc.$28
plus $113 from 5 others

What the payments were for

Food & beverage$492100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Neuronetics, Inc.	2	$150
Supernus Pharmaceuticals, Inc.	4	$85
Indivior Inc.	2	$46
Vanda Pharmaceuticals Inc.	2	$36
Teva Pharmaceuticals USA, Inc.	2	$34
Neurocrine Biosciences, Inc.	2	$28
Tempus AI, Inc	1	$27
Lundbeck LLC	2	$27
BD	1	$21
Novo Nordisk	1	$19
Axsome Therapeutics, Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NEUROSTAR TMS THERAPY SYSTEM$126

How this compares

$492 in reported general payments places this provider in the 90th percentile of 407 psychiatric/mental health providers in Minnesota.

See all psychiatric/mental health providers in Minnesota →

Medicare billing

Part B allowed, 2024

$14,971

Medicare patients

Services billed

174

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
VraylarCariprazine Hcl	56	$87,026
CaplytaLumateperone Tosylate	22	$43,406
Atomoxetine Hcl	33	$2,924
Lamotrigine	124	$1,728
Vilazodone Hcl	19	$1,706
Gabapentin	117	$1,513
Buspirone Hcl	74	$1,461
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	13	$1,230
Quetiapine Fumarate	55	$1,173
Duloxetine Hcl	76	$1,171
Zolpidem Tartrate	26	$1,018
Ramelteon	14	$887
Clonazepam	17	$756
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	16	$723
Trazodone Hcl	60	$570

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Cambridge

Sara OckerCambridge$3K
Wendi TvedtCambridge$526
Jacqualine GervaisMoorhead$29K
Naomi KoenigSandstone$8K
Dana BageonWayzata$7K
Jill ScottAnoka$5K
Holly WillisMinneapolis$5K
Gerard BalanMinneapolis$5K
Hilary BreedonShakopee$3K
Tina AlexanderEdina$3K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →